Business Wire

3,000% Increase in Firms Capturing ChatGPT Communications, Report Finds

11.11.2025 17:03:00 CET | Business Wire | Press Release

Share

Global Relay, a leading provider of end-to-end compliance solutions for highly regulated industries, has shared the findings of its third annual report which unveils the communications channels firms are compliantly capturing and prioritizing as emerging recordkeeping risks.

Informed by the data of over 12,000 financial institutions, exploring more than 200 communications channels, the Communication Capture Trends Report 2025 has found significant shifts in the communications and recordkeeping landscape. Between 2024 and 2025, changing workforces have seen new communications channels coming to the fore, thereby changing the communications risk landscape:

  • Almost 3,000%: The increase in the number of firms capturing ChatGPT data compared to 2024, with 100% of these firms based in North America
  • More than 2,000%: Increase in the number of firms capturing data from TikTok year-on-year
  • 114%: The increase in the number of firms capturing Apple® Messages

While more “traditional” business communications channels continue to constitute the top three most captured overall, including email (89% of Global Relay’s sample accounts), LinkedIn Personal Accounts (23%), and Microsoft Teams (23%), the largest increases demonstrate how firms may be reacting to current regulatory themes and compliance challenges, and provide insights on what their 2026 priorities will be:

  • ChatGPT vs. DOJ: 100% of the surveyed accounts capturing ChatGPT were based in North America, after the DOJ expanded its requirements that firms capture all relevant business and communications data – including AI chatbot logs.
  • Playing by the Marketing Rule: With more than $2 million in fines issued for SEC Marketing Rule violations in the last year, 33% more firms are capturing social channels, in particular TikTok data.
  • Ongoing fallout of WhatsApp fines: There has been a 36% YoY increase in the number of firms capturing WhatsApp, with 89% of those firms based in North America, signaling that perhaps firms are concerned about off-channel communications risk after years of aggressive regulatory enforcement.

“Compliance teams, and the firms they’re a part of, increasingly find themselves between the ‘rock’ of regulatory expectations and the ‘hard place’ of rapidly evolving technologies,” says Ryan Sheridan, Global Relay Senior Manager, Regulatory Intelligence. “The last few years of regulatory enforcement have sunk in, and firms are clearly investing in compliance solutions in-line with regulatory focuses like off-channel communications and the SEC’s Marketing Rule.”

“Given that it was U.S. regulators setting the pace of these enforcements, it’s unsurprising to see North American firms are working to stay ahead of emerging channels like ChatGPT and TikTok and the risks they might present. While ‘traditional’ business-as-usual channels like email remain firmly in the mix, the data shows just how quickly compliance priorities can shift – and it will be very interesting to see how these results stack up compared to 2026’s.”

The Communication Capture Trends Report series gives an annual snapshot of changing communications compliance priorities, leveraging the proprietary data of over 12,000 firms to provide an overview of how firms are reacting to regulatory requirements, emerging technologies, and evolving compliance challenges.

About Global Relay

Global Relay is a leading provider of end-to-end compliance solutions for the global financial sector and other highly regulated industries.

Founded in 1999, Global Relay delivers services to over 20,000 customers in 90 countries, including 22 of the top 25 banks. From the Global Relay App for compliant communications, through to intelligent archiving, superior data connectors, and proactive surveillance, Global Relay’s integrated compliance solutions enable regulated organizations to meet collaboration, privacy, and security requirements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251111056565/en/

Contacts

Media contact:
Emily Visco
globalrelay@aspectusgroup.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye